Research Roundup: Vitamin D, Treat-to-Target, Tocilizumab for Giant Cell Arteritis

Vitamin D’s failed treatment to prevent tibial cartilage loss and tocilizumab for giant cell arteritis represent a small sample of studies of interest that were published in top journals this month.

Vitamin D’s failed treatment to prevent tibial cartilage loss; treat-to-target for quality of life in rheumatoid arthritis; tocilizumab for giant cell arteritis; the protective role of sclerostin in TNF-mediated chronic inflammation and mind-body medicine for lower back pain represent a small sample of studies of interest that were published in top journals this month.

Related Videos
Video 3 -  4 KOLs are featured in, "Collaborating with Specialists: Primary Care Clinician’s Evolving Role in HE Management"
Video 3 -  4 KOLs are featured in, "HE Experts on Symptoms, Risk Factors, Diagnosis Challenges, and Severity Grading"
Shauna Applin, ARNP, an expert on HIV
© 2024 MJH Life Sciences

All rights reserved.